The Online Investor
NRC Buyback image

National Research Corporation Buyback

OLI recorded this information on 5/20/2022

Company: National Research Corporation
Buyback: NRC buyback
Share Amount Authorized: 2,500,000
Buyback Details: National Research Corporation, dba NRC Health (the "Company"), (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.24 (twenty-four cents) per share payable Friday, July 15, 2022, to shareholders of record as of the close of business on Thursday, June 30, 2022. Also, on May 19, 2022, the Company's Board of Directors approved a new stock repurchase authorization of up to 2.5 million shares of its common stock. The Company is authorized to repurchase from time-to-time shares of its outstanding common stock on the open market or in privately negotiated transactions. The timing and amount of stock repurchases will depend on a variety of factors, including market conditions as well as corporate and regulatory considerations. The stock repurchase authorization may be suspended, modified, or discontinued at any time and the Company has no obligation to repurchase any amount of its common stock in connection with the repurchase authorization. The repurchase authorization has no set expiration date. The new authorization follows the Company's recent repurchase of all shares remaining under the Board's previous repurchase authorization.

National Research is a provider of analytics and insights that facilitate measurement and improvement of patient engagement and customer loyalty for healthcare organizations. Co.'s portfolio of subscription-based solutions provides information and analysis to healthcare organizations across a range of elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management and brand loyalty. Co. partners with clients across the continuum of healthcare services. Co.'s digital solutions consist of three primary solution categories including Market Insights solutions, Transparency solutions, and Experience solutions.

NRC SEC Filing Email Alerts Service

Open the NRC Page at The Online Investor »

Company Name: 
National Research Corp
Stock buyback: 
NRC buyback
Website: 
www.nrchealth.com
Sector: 
Diagnostics
Number of ETFs Holding NRC: 
25
Total Market Value Held by ETFs: 
$50.10M
Total Market Capitalization: 
$817.00M
% of Market Cap. Held by ETFs: 
6.13%
 

Open the NRC Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree NRC Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
36th percentile
(ranked lower than approx. 64% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

NRC Buyback Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.